| Stage | DUK | % of rev | NWE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.6B | 100.00% | $393M | 100.00% | DUK ×19.34 |
| Gross profit | $4.2B | 54.82% | $224M | 56.97% | NWE +2.2pp |
| Operating income | $2.0B | 26.99% | $64M | 16.36% | DUK +10.6pp |
| Pre-tax income | $1.3B | 17.19% | $28M | 7.25% | DUK +9.9pp |
| Net income | $1.1B | 15.08% | $25M | 6.37% | DUK +8.7pp |
| Stage | DUK | NWE | Gap · A − B |
|---|---|---|---|
| Revenue | $7.6B100.00% | $393M100.00% | DUK ×19.34 |
| Gross profit | 54.82%$4.2B | 56.97%$224M | NWE +2.2pp |
| Operating income | 26.99%$2.0B | 16.36%$64M | DUK +10.6pp |
| Pre-tax income | 17.19%$1.3B | 7.25%$28M | DUK +9.9pp |
| Net income |
| 15.08%$1.1B |
| 6.37%$25M |
| DUK +8.7pp |
No shared counterparties.